Uppgifter: Pfizer ger sig in i kampen om Medivation

Sanofi S.A. är ett franskt läkemedelsföretag, med huvudkontor i Paris. Sanofi bildades 2004 genom en sammanslagning av Sanofi-Synthélabo och Aventis. Det är ett av de största läkemedelsföretagen i världen, med en omsättning på ca 27 miljarder euro.

Medivation is an American biopharmaceutical company focused on rapid development of novel therapies to treat serious diseases for which there are limited treatment options. Medivation, in collaboration with Astellas, is currently developing enzalutamide for multiple stages of prostate cancer and for breast cancer. On August 31, 2012, Medivation and Astellas announced that the U.S. Food and Drug Administration (FDA) granted approval to XTANDI® (enzalutamide) capsules for the treatment of patients with metastatic castration-resistant prostate cancer who have previously received docetaxel. XTANDI is an oral, once-daily androgen receptor inhibitor. Medivation is headquartered in San Francisco, California, and it began operations in December 2004 with the acquisition of Medivation Neurology, Inc. The current CEO is David Hung.